<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01902901</url>
  </required_header>
  <id_info>
    <org_study_id>1UM1HG007292-01</org_study_id>
    <secondary_id>1UM1HG007292-01</secondary_id>
    <nct_id>NCT01902901</nct_id>
  </id_info>
  <brief_title>Clinical Implementation of Carrier Status Using Next Generation Sequencing</brief_title>
  <acronym>NextGen</acronym>
  <official_title>Clinical Implementation of Carrier Status Using Next Generation Sequencing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Human Genome Research Institute (NHGRI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is conducting a randomized controlled trial (RCT) with up to 400 subjects (women &amp;
      partners) seeking pre-conception carrier testing to assess the impact of the program using
      Whole Genome Sequencing (WGS).

        1. The investigators hypothesize that whole genome sequencing will increase the detection
           of carrier status for Mendelian recessive and x-linked conditions.

        2. The investigators hypothesize that parents will act on the knowledge of their carrier
           status by making different reproductive choices than parents who do not receive this
           information.

        3. The investigators hypothesize that the psychosocial risks are increased among parents
           who receive expanded carrier screening using Next Generation Sequencing (NGS) compared
           with usual care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Project 1-Clinical Intervention and Outcomes Aim 1: To conduct a randomized controlled trial
      (RCT) with up to 400 subjects (women &amp; partners) seeking pre-conception carrier testing to
      assess the impact of the program using Whole Genome Sequencing (WGS).

      Aim 2: To develop processes for delivering information from WGS directly into the patient's
      electronic medical record, and establish innovative reporting strategies that are informative
      for clinicians and couples acting on this information.

      Aim 3: To measure for the integration of sequence information in clinical care for both
      carrier status and secondary findings including:

        1. Patient reported outcomes (PRO) on the impact on quality of life, satisfaction with
           care, timeliness of reporting, and use of the genomic information.

        2. Process outcomes such as timeliness, number of reportable findings, and time of
           interpretation.

      Project 2 -WGS technology, informatics, and Return of Results Committee (RORC)

      Aim 1: To generate whole genome sequence and interpret variants on samples randomized from
      the Kaiser Permanente Northwest (KPNW) preconception carrier screening cohort.

        1. To perform whole genome sequencing, assembly, and variant detection for each sample.

        2. To provide variant data on each sample with annotation and ranking of clinical
           significance.

        3. To validate data using an orthogonal platform for findings relevant to carrier status
           and actionable secondary findings.

      Aim 2: To develop and implement a return of results committee (RORC) that incorporates
      evidence to assess criteria for reporting carrier status for reproductive decision making and
      secondary findings.

      Project 3 - Ethical and Psychosocial Implications

      Aim 1: To evaluate, patient and clinical perspectives on informational needs, satisfaction,
      knowledge, and decision-making relating to the choice to obtain results of carrier status
      from WGS in four categories of genetic conditions.

      Aim 2: To evaluate, from patient and clinician perspectives, the immediate and downstream
      ethical, psychosocial, and behavioral consequences of expanded carrier screening using WGS.

      Aim 3: To evaluate the impact of expanded carrier test using WGS on subsequent health care
      utilization, and to compare the cost of delivery WGS to usual care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients That Receive Carrier Testing and Have Results to Return</measure>
    <time_frame>Assessed annually for 4 years, data at the end of the study reported.</time_frame>
    <description>The investigators will record the number of patients that have both single carrier status testing (usual care) and WGS testing and track how many patients have results to return.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>Assessed annually for 4 years, data at the end of Year 3 reported.</time_frame>
    <description>Through surveys, interviews, and observations with patients, the investigators will assess their satisfaction with the testing and return of results process.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Healthcare Utilization</measure>
    <time_frame>The end of Year 4</time_frame>
    <description>The investigators will evaluate if expanded carrier testing using WGS causes an increase in subsequent health care utilization compared to usual care (typically just cystic fibrosis carrier testing).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">384</enrollment>
  <condition>Genetic Disorders</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Requested carrier status testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Whole Genome Sequencing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These participants will receive the carrier status testing they requested from their provider, plus whole genome sequencing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Whole Genome Sequencing</intervention_name>
    <description>Participants will receive Whole Genome Sequencing</description>
    <arm_group_label>Whole Genome Sequencing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Carrier status testing</intervention_name>
    <description>Carrier status testing</description>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_label>Whole Genome Sequencing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Seeking pre-conception carrier status testing or had carrier testing during pregnancy

          -  Women with a male partner that can be contacted

          -  Kaiser Permanente Northwest members

          -  English speaking

          -  Not currently pregnant

        Exclusion Criteria:

          -  Currently pregnant

          -  No known or accessible male partner

          -  Not an English speaker

          -  Not a Kaiser Permanente member
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katrina Goddard, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benjamin Wilfond, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seattle Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaiser Permanente Northwest</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>July 10, 2013</study_first_submitted>
  <study_first_submitted_qc>July 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2013</study_first_posted>
  <results_first_submitted>June 20, 2018</results_first_submitted>
  <results_first_submitted_qc>February 20, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">March 13, 2019</results_first_posted>
  <last_update_submitted>April 8, 2019</last_update_submitted>
  <last_update_submitted_qc>April 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Whole Genome Sequencing</keyword>
  <keyword>Carrier status</keyword>
  <keyword>Genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genetic Diseases, Inborn</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Genome sequencing data is shared with dbGaP, and variants are shared with Clinvar.</ipd_description>
    <ipd_time_frame>Ongoing</ipd_time_frame>
    <ipd_access_criteria>Request to dbGaP</ipd_access_criteria>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>One person consented, but then immediately declined while doing the baseline survey, so she was never randomized.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Usual Care</title>
          <description>Requested carrier status testing.
Carrier status testing: Carrier status testing</description>
        </group>
        <group group_id="P2">
          <title>Whole Genome Sequencing</title>
          <description>These participants will receive the carrier status testing they requested from their provider, plus whole genome sequencing.
Whole Genome Sequencing: Participants will receive Whole Genome Sequencing
Carrier status testing: Carrier status testing</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="180"/>
                <participants group_id="P2" count="203"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="180"/>
                <participants group_id="P2" count="201"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>381 participants completed the baseline survey and had data for analysis. One person in the usual care arm did not complete the baseline survey, and one person in the whole genome sequencing arm completed the baseline survey and then disenrolled from the study a few months later.</population>
      <group_list>
        <group group_id="B1">
          <title>Usual Care</title>
          <description>Requested carrier status testing.
Carrier status testing: Carrier status testing</description>
        </group>
        <group group_id="B2">
          <title>Whole Genome Sequencing</title>
          <description>These participants will receive the carrier status testing they requested from their provider, plus whole genome sequencing.
Whole Genome Sequencing: Participants will receive Whole Genome Sequencing
Carrier status testing: Carrier status testing</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="179"/>
            <count group_id="B2" value="202"/>
            <count group_id="B3" value="381"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Online survey conducted at the consent visit</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="179"/>
                    <measurement group_id="B2" value="202"/>
                    <measurement group_id="B3" value="381"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32" spread="4.2"/>
                    <measurement group_id="B2" value="33" spread="4.6"/>
                    <measurement group_id="B3" value="32" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="179"/>
                    <measurement group_id="B2" value="131"/>
                    <measurement group_id="B3" value="310"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="166"/>
                    <measurement group_id="B2" value="188"/>
                    <measurement group_id="B3" value="354"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                    <measurement group_id="B2" value="163"/>
                    <measurement group_id="B3" value="306"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="159"/>
                    <measurement group_id="B2" value="153"/>
                    <measurement group_id="B3" value="312"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients That Receive Carrier Testing and Have Results to Return</title>
        <description>The investigators will record the number of patients that have both single carrier status testing (usual care) and WGS testing and track how many patients have results to return.</description>
        <time_frame>Assessed annually for 4 years, data at the end of the study reported.</time_frame>
        <population>All consented participants, including male partners.</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Requested carrier status testing.
Carrier status testing: Carrier status testing</description>
          </group>
          <group group_id="O2">
            <title>Whole Genome Sequencing</title>
            <description>These participants will receive the carrier status testing they requested from their provider, plus whole genome sequencing.
Whole Genome Sequencing: Participants will receive Whole Genome Sequencing
Carrier status testing: Carrier status testing</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients That Receive Carrier Testing and Have Results to Return</title>
          <description>The investigators will record the number of patients that have both single carrier status testing (usual care) and WGS testing and track how many patients have results to return.</description>
          <population>All consented participants, including male partners.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="180"/>
                <count group_id="O2" value="202"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <description>Through surveys, interviews, and observations with patients, the investigators will assess their satisfaction with the testing and return of results process.</description>
        <time_frame>Assessed annually for 4 years, data at the end of Year 3 reported.</time_frame>
        <population>Participants in the usual care arm don't complete satisfaction surveys. Results are WGS arm participants who received genetic testing carrier results in person and reported understanding the information</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Requested carrier status testing.
Carrier status testing: Carrier status testing</description>
          </group>
          <group group_id="O2">
            <title>Whole Genome Sequencing</title>
            <description>These participants will receive the carrier status testing they requested from their provider, plus whole genome sequencing.
Whole Genome Sequencing: Participants will receive Whole Genome Sequencing
Carrier status testing: Carrier status testing</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>Through surveys, interviews, and observations with patients, the investigators will assess their satisfaction with the testing and return of results process.</description>
          <population>Participants in the usual care arm don't complete satisfaction surveys. Results are WGS arm participants who received genetic testing carrier results in person and reported understanding the information</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="142"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Healthcare Utilization</title>
        <description>The investigators will evaluate if expanded carrier testing using WGS causes an increase in subsequent health care utilization compared to usual care (typically just cystic fibrosis carrier testing).</description>
        <time_frame>The end of Year 4</time_frame>
        <population>This data was reported at the end of year 4 for all participants that had at least 6 months of follow-up data.</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Requested carrier status testing.
Carrier status testing: Carrier status testing</description>
          </group>
          <group group_id="O2">
            <title>Whole Genome Sequencing</title>
            <description>These participants will receive the carrier status testing they requested from their provider, plus whole genome sequencing.
Whole Genome Sequencing: Participants will receive Whole Genome Sequencing
Carrier status testing: Carrier status testing</description>
          </group>
        </group_list>
        <measure>
          <title>Healthcare Utilization</title>
          <description>The investigators will evaluate if expanded carrier testing using WGS causes an increase in subsequent health care utilization compared to usual care (typically just cystic fibrosis carrier testing).</description>
          <population>This data was reported at the end of year 4 for all participants that had at least 6 months of follow-up data.</population>
          <units>Face to face medical encounters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
                <count group_id="O2" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" spread="10"/>
                    <measurement group_id="O2" value="10" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Usual Care</title>
          <description>Requested carrier status testing.
Carrier status testing: Carrier status testing</description>
        </group>
        <group group_id="E2">
          <title>Whole Genome Sequencing</title>
          <description>These participants will receive the carrier status testing they requested from their provider, plus whole genome sequencing.
Whole Genome Sequencing: Participants will receive Whole Genome Sequencing
Carrier status testing: Carrier status testing</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="180"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="203"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="180"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="203"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="180"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="203"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Katrina Goddard</name_or_title>
      <organization>Kaiser Permanente Center for Health Research</organization>
      <phone>503-335-6353</phone>
      <email>katrina.ab.goddard@kpchr.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

